Molecular Pharmaceutics

6 ta ish

Jurnal · ISSN 1543-8384

1. Lactoferrin-Modified Gambogic Acid Liposomes for Colorectal Cancer Treatment

   Rong Wang, Jingkun Qu, Xueping Tang +7

   MaqolaImmune cells in cancerMolecular Pharmaceutics20230 iqtibos

   ABIABI:AkademIndex/openalex/2023.article.000496

2. Structural Optimization of Fibroblast Activation Protein Inhibitors Through Zwitterionic and PEG Modification Strategy: Impact on Pharmacokinetics and Tumor Imaging

   Hongmei Yuan, Haiyang Li, Tongtong Wu +8

   MaqolaPeptidase Inhibition and AnalysisMolecular Pharmaceutics20250 iqtibos

   ABIABI:AkademIndex/openalex/2025.article.000352

3. Evaluation of [¹⁸F]F-PTTP as a Positron Emission Tomography Radioligand for Imaging P2X7 Receptors in Epileptic Rats

   Wenhui Fu, Zhequan Fu, Dai Shi +7

   MaqolaAdenosine and Purinergic SignalingMolecular Pharmaceutics20250 iqtibos

   ABIABI:AkademIndex/openalex/2025.article.000810

4. Development of Novel Peptide-Based ⁶⁸Ga-Labeled Radiotracers for Detecting ROR1 Expression in Tumors

   Shuhui Huang, Tian Tian, Mengfang Qi +3

   MaqolaRNA Research and SplicingMolecular Pharmaceutics20250 iqtibos

   ABIABI:AkademIndex/openalex/2025.article.001336

5. Immuno-PET Imaging of Tumor Mesothelin Expression with a Gallium-68 Radiolabeled Nanobody

   Xiaoying Lv, Yueling Deng, Xiangming Song +7

   MaqolaRadiopharmaceutical Chemistry and ApplicationsMolecular Pharmaceutics20260 iqtibos

   ABIABI:AkademIndex/openalex/2026.article.001170

6. Novel Covalent FAP-Targeted [ ⁶⁸ Ga]Ga-DOTA-mFS-KERERG-FAP-2286 for Improved Pharmacokinetics and Enhanced Tumor Uptake

   Zhongcai Jin, Tongtong Wu, Shijie Tang +12

   MaqolaPeptidase Inhibition and AnalysisMolecular Pharmaceutics20260 iqtibos

   ABIABI:AkademIndex/openalex/2026.article.014250